Delving Into Participation Trends in Renal Cell Carcinoma Studies

Starting soon

Conditions studied: Renal Cell Carcinoma

In brief

The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.

Key facts

Study ID

NCT06093568

Run by

Power Life Sciences Inc.

People needed

500

Starts

2024-11-01

Expected to finish

2026-11-01

Last updated by the study team

2023-10-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has been diagnosed with renal cell carcinoma
• Patient is a minimum of 18 years or older
• Patient has self-identified as planning to enroll in a clinical study

You may not qualify if…

• Patient does not understand, sign, and return consent form
• Inability to perform regular electronic reporting
• Patient is pregnant

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.